SynAct Pharma’s Shares Offering

Baker McKenzie acted as legal advisor to ABG Sundal Collier. SynAct Pharma completed a primary issuance of shares of approximately SEK 80 million at a subscription…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here